Oturum Aç

Michael Wilschanski

Hadassah Hebrew University Medical Center, Jerusalem

BIOGRAPHY

Michael Wilschanski has not added Biography.

If you are Michael Wilschanski and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Combination of Helicobacter pylori strain and tumor necrosis factor-alpha polymorphism of the host increases the risk of peptic ulcer disease in children.

Journal of pediatric gastroenterology and nutrition Aug, 2007 | Pubmed ID: 17667716

Patterns of gastrointestinal disease associated with mutations of CFTR.

Current gastroenterology reports Jun, 2008 | Pubmed ID: 18625144

Small molecules to treat cystic fibrosis.

Proceedings of the American Thoracic Society Nov, 2010 | Pubmed ID: 21030520

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.

The European respiratory journal Jul, 2011 | Pubmed ID: 21233271

New drugs for cystic fibrosis.

Expert opinion on investigational drugs Sep, 2011 | Pubmed ID: 21745147

Novel therapeutic approaches for cystic fibrosis.

Discovery medicine Feb, 2013 | Pubmed ID: 23449115

Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

Digestive diseases and sciences Jan, 2016 | Pubmed ID: 26250833

ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis.

Clinical nutrition (Edinburgh, Scotland) 06, 2016 | Pubmed ID: 27068495

Introduction.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Nov, 2017 | Pubmed ID: 28986025

Advancing the GI frontier for patients with CF.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Jan, 2018 | Pubmed ID: 29208346

Cystic fibrosis: a gastrointestinal cancer syndrome.

The Lancet. Oncology Jun, 2018 | Pubmed ID: 29706381

Primary sclerosing cholangitis is associated with abnormalities in CFTR.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Sep, 2018 | Pubmed ID: 29807875

INSTITUTIONS

Hadassah Hebrew University Medical Center, Jerusalem

JOVE ARTICLES

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)

George M. Solomon¹,

Inez Bronsveld²,

Kathryn Hayes³,

Michael Wilschanski⁴,

Paola Melotti⁵,

Steven M. Rowe¹,

Isabelle Sermet-Gaudelus^6,7

¹Department of Medicine and the Gregory Fleming James Cystic Fibrosis Center, University of Alabama at Birmingham,

²Department of Pulmonology and Tuberculosis, University Medical Center Utrecht,

³Center for Experimental Medicine, Queens University, Northern Ireland,

⁴, Hadassah Hebrew University Medical Center, Jerusalem,

⁵Centro Fibrosi Cistica, Azienda Ospedaliera Universitaria Integrata,

⁶Service de Pneumologie et Allergologie Pédiatriques and Center de Ressources et de Compétence de la Mucoviscidose, Hôpital Necker Enfants Malades,

⁷INSERM U 1151, Institut Necker Enfants Malades

Medicine

Gizlilik

Kullanım Şartları

İlkeler

Bize Ulaşın

KÜTÜPHANEYE TAVSİYE ET

JoVE HABER BÜLTENLERİ

Araştırma

JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv

Eğitim

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Fakülte sitesi

Yazarlar

Genel Bakış
Yayın Süreci
Editör Kurulu
Kapsam ve İlkeler
Hakem Denetimi
SSS
Gönder

Kütüphaneciler

Genel Bakış
Görüşler | JoVE
Abonelikler
Erişim
Kaynaklar
Kütüphane Danışma Kurulu
SSS

JoVE Hakkında

Genel Bakış
Liderlik
Blog
JoVE Help Center